Reference health

CU06-1004 Modulates the Adenosine Monophosphate (AMP)-Associated Protein Kinase (AMPK) Signaling Pathway and Inhibits Lipogenesis in 3T3-L1 Adipocytes and High-Fat Diet-Induced Obese Mice

https://doi.org/10.2139/ssrn.3974363
CiteStamped reference-health badge
35/35 checkable references clean · checked 2026-09-08

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 35 checked references that resolve
resolves10.1161/CIRCULATIONAHA.111.087213
Energy Balance and Obesity
resolves10.3390/ijms20092358
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
resolves10.1210/rp.59.1.207
Obesity, Insulin Resistance, and Cardiovascular Disease
resolves10.1038/sj.ijo.0800770
Adipose tissue as an endocrine and paracrine organ
resolves10.1016/j.mam.2012.10.001
Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications
resolves10.1002/jsfa.6604
Quercetin‐rich onion peel extract suppresses adipogenesis by down‐regulating adipogenic transcription factors and gene expression in <scp>3T3‐L1</scp> adipocytes
resolves10.1172/JCI29044
AMP-activated protein kinase signaling in metabolic regulation
resolves10.2147/JEP.S181642
&lt;p&gt;Bioactive fraction from &lt;em&gt;Lagerstroemia speciosa&lt;/em&gt; leaves (DLBS3733) reduces fat droplet by inhibiting adipogenesis and lipogenesis&lt;/p&gt;
resolves10.1155/2017/1459497
The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity
resolves10.1097/MED.0b013e3283514e13
What causes the insulin resistance underlying obesity?
resolves10.1172/JCI200319246
Obesity is associated with macrophage accumulation in adipose tissue
resolves10.1016/j.bbrc.2013.04.104
Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway
resolves10.1186/s12974-017-0897-3
Sac-1004, a vascular leakage blocker, reduces cerebral ischemia—reperfusion injury by suppressing blood–brain barrier disruption and inflammation
resolves10.1007/s00109-020-01920-z
CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury
resolves10.1016/j.juro.2015.12.103
Sac-1004, a Pseudo-Sugar Derivative of Cholesterol, Restores Erectile Function through Reconstruction of Nonleaky and Functional Cavernous Angiogenesis in the Streptozotocin Induced Diabetic Mouse
resolves10.3164/jcbn.09-83
A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet
resolves10.1006/meth.2001.1262
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
resolves10.1016/j.cmet.2006.05.005
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
resolves10.1038/aps.2013.39
Danthron activates AMP-activated protein kinase and regulates lipid and glucose metabolism in vitro
resolves10.1172/JCI10842
Obesity and insulin resistance
resolves10.1007/s00125-012-2811-y
Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects
resolves10.1152/ajpcell.00379.2020
Adipose tissue inflammation and metabolic dysfunction in obesity
resolves10.1016/j.diff.2014.07.002
Adipocyte transdifferentiation and its molecular targets
resolves10.1101/gad.948702
C/EBPα induces adipogenesis through PPARγ: a unified pathway
resolves10.1038/nrendo.2015.122
Metabolic functions of FABPs—mechanisms and therapeutic implications
resolves10.1146/annurev.biochem.77.061307.091829
Fat and Beyond: The Diverse Biology of PPARγ
resolves10.1016/j.cmet.2009.03.012
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
resolves10.1021/acsomega.0c02525
Laquinimod Prevents Adipogenesis and Obesity by Down-Regulating PPAR-γ and C/EBPα through Activating AMPK
resolves10.1016/j.tem.2017.05.004
AMPK as a Therapeutic Target for Treating Metabolic Diseases
resolves10.1530/JOE-13-0339
Adipocytokines in obesity and metabolic disease
resolves10.1172/JCI129191
Contribution of adipogenesis to healthy adipose tissue expansion in obesity
resolves10.1161/CIRCRESAHA.119.315896
Metabolic Inflammation and Insulin Resistance in Obesity
resolves10.1055/s-0029-1192044
Adipose Tissue Dysfunction in Obesity
resolves10.1172/JCI29881
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
resolves10.1016/j.bpg.2014.07.008
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
The 7 references without a DOI — listed, not checked
no DOI — not checkedEGCG reduces obesity and white adipose tissue gain partly through AMPK activation in mice
no DOI — not checkedCU06-1004 alleviates experimental colitis by modulating colonic vessel dysfunction
no DOI — not checkedCU06-1004-induced vascular normalization improves immunotherapy by modulating tumor microenvironment via cytotoxic T cells
no DOI — not checkedThe endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
no DOI — not checkedAnti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism
no DOI — not checkedDiet-induced obesity in animal models: points to consider and influence on metabolic markers
no DOI — not checkedSREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-09-08 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.3974363"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3974363/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.3974363/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.3974363)